US20080194931A1 - Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles - Google Patents
Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles Download PDFInfo
- Publication number
- US20080194931A1 US20080194931A1 US12/002,678 US267807A US2008194931A1 US 20080194931 A1 US20080194931 A1 US 20080194931A1 US 267807 A US267807 A US 267807A US 2008194931 A1 US2008194931 A1 US 2008194931A1
- Authority
- US
- United States
- Prior art keywords
- isosbestic
- oxygen saturation
- hemoglobin
- measurement
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 26
- 239000001301 oxygen Substances 0.000 title claims abstract description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 23
- 210000004369 blood Anatomy 0.000 title claims abstract description 19
- 239000008280 blood Substances 0.000 title claims abstract description 19
- 230000003287 optical effect Effects 0.000 title claims abstract description 8
- 238000001228 spectrum Methods 0.000 claims abstract description 32
- 108010054147 Hemoglobins Proteins 0.000 claims abstract description 25
- 102000001554 Hemoglobins Human genes 0.000 claims abstract description 25
- 108010064719 Oxyhemoglobins Proteins 0.000 claims abstract description 17
- 230000005540 biological transmission Effects 0.000 claims abstract description 9
- 238000012937 correction Methods 0.000 claims description 7
- 238000005259 measurement Methods 0.000 abstract description 64
- 230000008033 biological extinction Effects 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 10
- 230000009102 absorption Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000001210 retinal vessel Anatomy 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000012623 in vivo measurement Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002496 oximetry Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 210000001957 retinal vein Anatomy 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14555—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for the eye fundus
Definitions
- the invention is directed to a method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbance variables such as those also presented by pigmented and light-scattering surrounding tissue and/or also the vascular wall itself.
- This problem of determining the oxygen saturation of blood while excluding as far as possible the influence of these factors affecting measurement accuracy occurs particularly in noninvasive, in-vivo or in-vitro examinations of blood vessels located in front of, behind, or in said pigmented and scattering tissue, for example, in the examination of blood vessels of the ocular fundus or other tissue areas in the body such as the skin and organs that are accessible by endoscopy.
- the hemoglobin does not exist in isolation in in-vivo measurement, but is enclosed in the erythrocytes.
- the scattering of light on the erythrocytes has a considerable influence on the extinction spectrum of the blood.
- the influences of scattering and absorption can be separated.
- Pittman and Duling describe a method for determining the oxygen saturation in whole blood from measurements taken in transmission at a wavelength of 555 nm and at isosbestic points at 522 nm and 546 nm (Pittman, R.
- spectral measurements are generated by transmission measurement and reflection measurement in a measurement spectrum at wavelengths that are isosbestic for hemoglobin and oxyhemoglobin and at least one other measurement value is generated at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ, and these measurements are compared with known reference values of the reference spectra of hemoglobin and oxyhemoglobin in that:
- a reference function (F R ) is generated in the reference spectra from the reference values (R i1 , R i2 ) corresponding to the at least two measurement values (M i1 , M i2 ) determined in the measurement spectrum for the same isosbestic wavelengths ( ⁇ i1 , ⁇ i2 ) of hemoglobin and oxyhemoglobin, which reference function (F R ) is of the same type,
- a correction function (F K ) is generated from the auxiliary function (F H ) of the measurement spectrum in which said at least two measurement values (M i1 , M i2 ) lie for isosbestic wavelengths ( ⁇ i1 , ⁇ i2 ) and from the reference function (F R ) of the reference spectra in which the at least two reference values (R i1 , R i2 ) corresponding to the at least two measurement values (M i1 , M i2 ) lie, and a corrected auxiliary function (F Hk ) identical to the reference function (F R ) in the reference spectra is generated in a corrected measurement spectrum by means of this correction function (F K ), and
- the oxygen saturation of the blood is determined from the other measurement value (M a ′′) converted to the corrected auxiliary function (F Hk ) of the corrected measurement spectrum in relation to the reference values for hemoglobin and oxyhemoglobin at this wavelength ( ⁇ a ).
- the spectral measurement values and reference data are determined logarithmically and the auxiliary function and reference function are formed by a straight line on which two of the measurement values or reference values lie for isosbestic wavelengths.
- the correction function formed from the linear auxiliary function and reference function can also give a linear corrected auxiliary function of the corrected measurement spectrum.
- a constant multiplier is applied to the rest of the spectral measurement values, i.e., the spectral measurement value for the third isosbestic wavelength and the other measurement value at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ as far as possible in the reference spectra.
- This constant multiplier is determined in such a way that the third isosbestic measurement value of the corrected measurement spectrum that is corrected by scaling conforms to the corresponding reference value of the reference spectra.
- the difference between the reference values for hemoglobin and oxyhemoglobin can be scaled linearly between 0 and 1.
- the oxygen saturation of the blood is determined in relation to this scale from the other measurement value that is converted to the corrected auxiliary function of the corrected measurement spectrum.
- the oxygen saturation of the blood can be determined by the proposed method with the same accuracy but with substantially less effort (minimally, four measurement values are required) for measurement, calculation and evaluation.
- the method makes possible a two-dimensional, spatially dependent representation of the measurements allowing a manageable and fast evaluation. Only a few measurement values are required and only linear transformations are used. With these advantages of low expenditure and time-efficient measurement evaluation, the proposed method is also suitable for screening examinations as well as for routine and early detection examinations.
- FIG. 2 is a graph with spectral reference values according to FIG. 1 showing linear reference function F R and corrected measurement values M′;
- FIG. 3 is a graph with spectral reference values according to FIG. 1 showing linear reference function F R with corrected measurement values M′′ and with scaling for reading off oxygen saturation.
- FIG. 1 shows the measurement data and reference data represented logarithmically, which are, in this example, the reflection of a retinal vein (measurement data) and the transmission of a layer of whole blood with a thickness of 0.1 mm (reference data).
- measurement data the reflection of a retinal vein
- reference data the transmission of a layer of whole blood with a thickness of 0.1 mm
- a linear auxiliary function F H of the wavelength is calculated in the measurement spectra such that its values at the isosbestic wavelengths ⁇ i1 and ⁇ i2 agree with the measurement data M i1 and M i2 at these wavelengths.
- a linear reference function F R of the wavelength is calculated in the reference spectra in such a way that its values at the isosbestic wavelengths ⁇ i1 and ⁇ i2 agree with the reference data R i1 , R i2 at these wavelengths.
- FIG. 2 again shows the reference data, the linear reference function F R of the wavelength and the corrected measurement data M′.
- This correction compensates for extinctions which exist in addition to the absorption of the hemoglobin and whose spectra in the wavelength range of 522 nm to 586 nm can be assumed or approximated as linear in the logarithmic scale.
- the embodiment example under consideration concerns absorptions of melanin and the anterior optical media and the scattering in the blood and in the surrounding tissue.
- the corrected measurement data M′ are scaled by a factor of less than or greater than 1 around the linear reference function F R in such a way that they agree with the reference value R i3 at the isosbestic wavelength ⁇ i3 :
- M ⁇ ′′ F R ⁇ ( ⁇ ) + ( M ⁇ ′ - F R ⁇ ( ⁇ ) ) ⁇ ( R i ⁇ ⁇ 3 - F R ⁇ ( ⁇ 3 ) ) M i ⁇ ⁇ 3 ′ - F R ⁇ ( ⁇ 3 ) .
- FIG. 3 shows the spread (or scaling) of the corrected measurement data M′ resulting in M′′ around the linear reference function F R which is carried out in such a way that corrected measurement data and reference data agree at the isosbestic wavelength ⁇ i3 (569 nm). This correction compensates for different absolute values of the measurement data and reference data that occur due to different illumination conditions and measurement conditions.
- the scaled readout of the oxygen saturation (OS) between the values 0 and 1 is likewise shown in FIG. 3 .
- the oxygen saturation OS in the embodiment example is 0.69.
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Heart & Thoracic Surgery (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The invention is directed to a method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbance variables in which transmission measurements and reflection measurements are carried out in at least two wavelengths that are isosbestic for hemoglobin and oxyhemoglobin, and at least one other wavelength at which the extinction of hemoglobin and oxyhemoglobin differ. Corresponding auxiliary functions are defined in the measurement spectrum (M) and in the reference spectra of hemoglobin and oxyhemoglobin, at least two of the measurement values or two of the reference values for the isosbestic wavelengths lying on this auxiliary function. A corrected measurement spectrum (M″) is generated by means of the two auxiliary functions. The oxygen saturation is determined by comparing the changed data of this corrected measurement spectrum (M″) with the data of the reference spectra at the other wavelength.
Description
- The invention is directed to a method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbance variables such as those also presented by pigmented and light-scattering surrounding tissue and/or also the vascular wall itself. This problem of determining the oxygen saturation of blood while excluding as far as possible the influence of these factors affecting measurement accuracy occurs particularly in noninvasive, in-vivo or in-vitro examinations of blood vessels located in front of, behind, or in said pigmented and scattering tissue, for example, in the examination of blood vessels of the ocular fundus or other tissue areas in the body such as the skin and organs that are accessible by endoscopy.
- It is generally known that the absorption spectrum of the red blood pigment hemoglobin changes with oxygen saturation (e.g., van Assendelft, O. W., Spectrophotometry of heamoglobin derivatives, Assen: Royal Vangorcum, 1970). Accordingly, it is possible to determine the oxygen saturation of a hemoglobin sample by comparing the spectrum of the sample to the spectra of completely oxygenated and completely reduced hemoglobin.
- Recent work in oxymetry in the ocular fundus using the Lambert-Beerschen law, i.e., taking only absorption into account, has been published by Smith et al. and others (Smith, M. H., Denninghoff, K. R., Lompado, A., Hillman, L. W., Effect of multiple light paths in retinal vessel oxymetry, Appl. Opt. 39, 2000, 1183-1193). Numerous patented arrangements and methods are based on this principle (e.g., U.S. Pat. No. 4,485,820; U.S. Pat. No. 5,119,814; U.S. Pat. No. 5,308,919; U.S. Pat. No. 4,253,744; U.S. Pat. No. 4,305,398; U.S. Pat. No. 5,776,060; U.S. Pat. No. 5,935,076; DE 199 20 157 A1; U.S. Pat. No. 5,318,022).
- However, the hemoglobin does not exist in isolation in in-vivo measurement, but is enclosed in the erythrocytes. The scattering of light on the erythrocytes has a considerable influence on the extinction spectrum of the blood. However, based on the findings of the multiple scattering theory of Twersky (Twersky, V., Absorption and multiple scattering by biological suspensions, J. Opt. Soc. Amer. 60, 1970, 1084-1093), the influences of scattering and absorption can be separated. On this basis, Pittman and Duling describe a method for determining the oxygen saturation in whole blood from measurements taken in transmission at a wavelength of 555 nm and at isosbestic points at 522 nm and 546 nm (Pittman, R. N., Duling, B. R., A new method for the measurement of percent oxyhemoglobin, J. Appl. Physiol., 38, 1975, 315-320). This method has been used by Delori to determine oxygen saturation in retinal vessels (Delori, F. C., Noninvasive technique of oximetry of blood in retinal vessels, Appl. Opt. 27, 1988, 113-1125).
- However, investigations by Hammer at al. (Hammer, M., Leistritz, S., Leistritz, L., Schweitzer, D., Light paths in retinal vessel oxymetry, IEEE Trans Biomed Eng 48 (5), 2001, 592-8) show that the reflection spectra measured on retinal vessels are influenced not only by the absorption of the hemoglobin and the scattering in the blood and in the tissue surrounding the vessels, but also by the melanin located in the retinal pigment epithelium and in the choroid. This is also true of vessels in the skin or other pigmented organs.
- Correcting falsification of the hemoglobin spectra by means of other chromophores and correction for spectroscopic oxymetry have been attempted in previous literature by scaling the spectra measured on a vessel to measurements next to the vessel (e.g., DE 199 20 157 A1; U.S. Pat. No. 5,935,076; Delori, F. C., Noninvasive technique for oximetry of blood in retinal vessels, Appl. Opt. 27, 1988, 113-1125; Schweitzer, D., Hammer, M., Kraft, J., Thamm, E., Königsdörffer, E., Strobel, J., In Vivo Measurement of the Oxygen Saturation at the Normal Human Eye, IEEE Trans. Biomed. Eng. 46, 1999, 1454-1465). However, this approach does not take into account the extremely complicated relationships (Hammer, M., Leistritz, S., Leistritz, L., Schweitzer, D., Light paths in retinal vessel oxymetry, IEEE Trans Biomed Eng 48 (5), 2001, 592-8) of the beam propagation in the blood vessel and the tissue surrounding it.
- The exact light propagation in the biological tissue cannot always be fully described physically. Even efforts to recreate these processes for eliminating disturbances in the most comprehensive and realistic manner possible (DE 199 20 157 A1) and to model the optics of the living or dead biological tissue surrounding the blood vessel (DE 44 33 827 A1) have not led to more exact measurements than the methods mentioned above, which are already relatively time-consuming and require intensive computation. In view of this, the methods are only conditionally suitable especially for routine examinations and screening examinations. In particular, the determination of oxygen saturation at every point of a two-dimensional, graphic recording, which is important for clinical practice, requires a method that is fast on the one hand and that compensates for optical and spectrometric disturbances due to the tissue environment on the other hand.
- Therefore, it is the object of the invention to determine the oxygen saturation with high accuracy by a method which is as simple and as fast as possible.
- In order to meet the above-stated object, spectral measurements are generated by transmission measurement and reflection measurement in a measurement spectrum at wavelengths that are isosbestic for hemoglobin and oxyhemoglobin and at least one other measurement value is generated at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ, and these measurements are compared with known reference values of the reference spectra of hemoglobin and oxyhemoglobin in that:
- a) at least two said spectral measurement values (Mi1, Mi2) at wavelengths (λi1, λi2) that are isosbestic for hemoglobin and oxyhemoglobin and at least the other measurement value (Ma) at a wavelength (λa) at which the reference values of hemoglobin and oxyhemoglobin differ as far as possible in the reference spectra are detected in the measurement spectrum, wherein an auxiliary function (FH) is generated at least from two of the measurement values (Mi1, Mi2) for isosbestic wavelengths (λi1, λi2),
- b) a reference function (FR) is generated in the reference spectra from the reference values (Ri1, Ri2) corresponding to the at least two measurement values (Mi1, Mi2) determined in the measurement spectrum for the same isosbestic wavelengths (λi1, λi2) of hemoglobin and oxyhemoglobin, which reference function (FR) is of the same type,
- c) a correction function (FK) is generated from the auxiliary function (FH) of the measurement spectrum in which said at least two measurement values (Mi1, Mi2) lie for isosbestic wavelengths (λi1, λi2) and from the reference function (FR) of the reference spectra in which the at least two reference values (Ri1, Ri2) corresponding to the at least two measurement values (Mi1, Mi2) lie, and a corrected auxiliary function (FHk) identical to the reference function (FR) in the reference spectra is generated in a corrected measurement spectrum by means of this correction function (FK), and
- d) the oxygen saturation of the blood is determined from the other measurement value (Ma″) converted to the corrected auxiliary function (FHk) of the corrected measurement spectrum in relation to the reference values for hemoglobin and oxyhemoglobin at this wavelength (λa).
- It is advantageous when the spectral measurement values and reference data are determined logarithmically and the auxiliary function and reference function are formed by a straight line on which two of the measurement values or reference values lie for isosbestic wavelengths. The correction function formed from the linear auxiliary function and reference function can also give a linear corrected auxiliary function of the corrected measurement spectrum. A constant multiplier is applied to the rest of the spectral measurement values, i.e., the spectral measurement value for the third isosbestic wavelength and the other measurement value at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ as far as possible in the reference spectra. This constant multiplier is determined in such a way that the third isosbestic measurement value of the corrected measurement spectrum that is corrected by scaling conforms to the corresponding reference value of the reference spectra. In this specific case, the difference between the reference values for hemoglobin and oxyhemoglobin can be scaled linearly between 0 and 1. The oxygen saturation of the blood is determined in relation to this scale from the other measurement value that is converted to the corrected auxiliary function of the corrected measurement spectrum.
- For purposes of a clear two-dimensional representation of the oxygen saturation of the blood, four monochromatic individual images are generated at said wavelengths and the oxygen saturation is determined for each image point.
- Surprisingly, it has been shown that in comparison with the examination methods mentioned in the introduction, the oxygen saturation of the blood can be determined by the proposed method with the same accuracy but with substantially less effort (minimally, four measurement values are required) for measurement, calculation and evaluation. The method makes possible a two-dimensional, spatially dependent representation of the measurements allowing a manageable and fast evaluation. Only a few measurement values are required and only linear transformations are used. With these advantages of low expenditure and time-efficient measurement evaluation, the proposed method is also suitable for screening examinations as well as for routine and early detection examinations.
- The invention will be described more fully in the following with reference to an embodiment example shown in the drawing.
-
FIG. 1 is a graph showing measurement values and reference values in logarithmic form in the wavelength range between 400 nm and 700 nm, including three isosbestic wavelengths λi1=522 nm, λi2=586 nm, λi3=569 nm and the other wavelength λa=555 nm; -
FIG. 2 is a graph with spectral reference values according toFIG. 1 showing linear reference function FR and corrected measurement values M′; -
FIG. 3 is a graph with spectral reference values according toFIG. 1 showing linear reference function FR with corrected measurement values M″ and with scaling for reading off oxygen saturation. - The reflection or transmission of tissue at a point or with spatial resolution in an image is measured at three isosbestic wavelengths λi1, λi2 and λi3 (λi1=522 nm, λi2=586 nm, λi3=569 nm) as measurement data Mi1, Mi2 and Mi3 and at a different wavelength λa (555 nm), at which the absorption coefficients of oxygenated and reduced hemoglobin differ, as measurement value Ma and is compared with the reflection or transmission of hemoglobin or whole blood with oxygen saturations of 0% and 100%, respectively, at these wavelengths (reference data R1, R2, R3, Ra 0% and Ra 100%) according to the following method:
- 1. All measurement data and reference data are logarithmized.
FIG. 1 shows the measurement data and reference data represented logarithmically, which are, in this example, the reflection of a retinal vein (measurement data) and the transmission of a layer of whole blood with a thickness of 0.1 mm (reference data). For the sake of clarity, the complete spectra between 400 nm and 700 nm are shown. The wavelengths λi1=522 nm, λi2=586 nm, λi3=569 nm and λa=555 nm used in this example are shown. - 2. A linear auxiliary function FH of the wavelength is calculated in the measurement spectra such that its values at the isosbestic wavelengths λi1 and λi2 agree with the measurement data Mi1 and Mi2 at these wavelengths.
- 3. A linear reference function FR of the wavelength is calculated in the reference spectra in such a way that its values at the isosbestic wavelengths λi1 and λi2 agree with the reference data Ri1, Ri2 at these wavelengths.
- 4. The measurement data are corrected additively at each wavelength by the difference of the linear functions FH and FR in such a way that at the isosbestic wavelengths λi1 and λi2 they agree with the reference data: M′λ=Mλ+FR−FH.
-
FIG. 2 again shows the reference data, the linear reference function FR of the wavelength and the corrected measurement data M′. This correction compensates for extinctions which exist in addition to the absorption of the hemoglobin and whose spectra in the wavelength range of 522 nm to 586 nm can be assumed or approximated as linear in the logarithmic scale. The embodiment example under consideration concerns absorptions of melanin and the anterior optical media and the scattering in the blood and in the surrounding tissue. - 5. The corrected measurement data M′ are scaled by a factor of less than or greater than 1 around the linear reference function FR in such a way that they agree with the reference value Ri3 at the isosbestic wavelength λi3:
-
-
FIG. 3 shows the spread (or scaling) of the corrected measurement data M′ resulting in M″ around the linear reference function FR which is carried out in such a way that corrected measurement data and reference data agree at the isosbestic wavelength λi3 (569 nm). This correction compensates for different absolute values of the measurement data and reference data that occur due to different illumination conditions and measurement conditions. - 6. The position Of M″a on a scale contained linearly between Ra 0% and Ra 100% indicates the oxygen saturation OS:
-
- The scaled readout of the oxygen saturation (OS) between the
values FIG. 3 . The oxygen saturation OS in the embodiment example is 0.69. -
- M—measurement data
- M′—measurement data corrected by the addition of the corrected auxiliary function
- M″—measurement data M′ corrected by applying a factor
- FR—reference function
- OS—oxygen saturation
- λ—wavelength
Claims (3)
1-3. (canceled)
4. A method for determining the oxygen saturation of blood in the presence of optical disturbance variables, the method comprising:
generating at least two transmission or reflection isosbestic measuring values at wavelengths that are isosbestic for hemoglobin and oxyhemoglobin;
generating at least one transmission or reflection non-isosbestic measuring value at a wavelength that is non-isosbestic hemoglobin and oxyhemoglobin;
using the two isosbestic measuring values to determine a corrected function of the optical disturbance; and
using the correction function to determine the oxygen saturation.
5. A method for determining the oxygen saturation of blood in the presence of optical disturbance values, the method comprising:
generating at least one transmission or reflection non-isosbestic measuring value for a non-isosbestic wavelength for hemoglobin and oxyhemoglobin;
wherein the non-isosbestic measuring value for hemoglobin and the non-isosbestic measuring value for oxyhemoglobin duffer as far as possible in the reference spectra.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/002,678 US20080194931A1 (en) | 2002-04-17 | 2007-12-18 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10217543.8 | 2002-04-17 | ||
DE10217543A DE10217543B4 (en) | 2002-04-17 | 2002-04-17 | Method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbances |
PCT/EP2003/004024 WO2003086193A1 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
US10/511,483 US7333842B2 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
US12/002,678 US20080194931A1 (en) | 2002-04-17 | 2007-12-18 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/511,483 Continuation US7333842B2 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
PCT/EP2003/004024 Continuation WO2003086193A1 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080194931A1 true US20080194931A1 (en) | 2008-08-14 |
Family
ID=28798595
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/511,483 Expired - Fee Related US7333842B2 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
US12/002,678 Abandoned US20080194931A1 (en) | 2002-04-17 | 2007-12-18 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/511,483 Expired - Fee Related US7333842B2 (en) | 2002-04-17 | 2003-04-17 | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables |
Country Status (3)
Country | Link |
---|---|
US (2) | US7333842B2 (en) |
DE (1) | DE10217543B4 (en) |
WO (1) | WO2003086193A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080221416A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | System and method for detection of macular degeneration using spectrophotometry |
WO2017117668A1 (en) * | 2016-01-05 | 2017-07-13 | Vasile Diaconu | On line and real time optic nerve blood oxygenation mapping |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7449339B2 (en) * | 1999-11-23 | 2008-11-11 | Nir Diagnostics Inc. | Spectroscopic method and apparatus for total hemoglobin measurement |
AU2005226667B2 (en) * | 2004-03-19 | 2010-04-01 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | A method for evaluating relative oxygen saturation in body tissues |
DE102007053074A1 (en) * | 2007-08-03 | 2009-05-14 | Carl Zeiss Meditec Ag | Method and measuring device for fluorescence measurement on the eye |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
WO2017100685A1 (en) | 2015-12-10 | 2017-06-15 | Bioxytech Retina, Inc. | Methods and apparatus for measuring blood oxygenation of tissue |
JP6755831B2 (en) * | 2016-08-09 | 2020-09-16 | 花王株式会社 | How to evaluate skin condition |
DE102017210548A1 (en) * | 2017-06-22 | 2018-12-27 | Zf Friedrichshafen Ag | Thickness-independent spectroscopic analysis of consumables |
IL295373A (en) * | 2022-08-04 | 2024-03-01 | Spring Vision Ltd | Optical system and method for monitoring biological tissue condition |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4253744A (en) * | 1978-05-12 | 1981-03-03 | Minolta Camera Kabushiki Kaisha | Optical system for light measurement of an eye fund |
US4305398A (en) * | 1977-12-30 | 1981-12-15 | Minolta Camera Kabushiki Kaisha | Eye fundus oximeter |
US4485820A (en) * | 1982-05-10 | 1984-12-04 | The Johns Hopkins University | Method and apparatus for the continuous monitoring of hemoglobin saturation in the blood of premature infants |
US5119814A (en) * | 1990-07-25 | 1992-06-09 | Minnich Thomas E | Method and apparatus for monitoring blood loss via retinal venous oxygen saturation |
US5308919A (en) * | 1992-04-27 | 1994-05-03 | Minnich Thomas E | Method and apparatus for monitoring the arteriovenous oxygen difference from the ocular fundus |
US5318022A (en) * | 1991-03-01 | 1994-06-07 | John Taboada | Method and apparatus for determining hemoglobin oxygenation such as in ocular and other vascular beds |
US5776060A (en) * | 1997-02-20 | 1998-07-07 | University Of Alabama In Huntsville | Method and apparatus for measuring blood oxygen saturation within a retinal vessel with light having several selected wavelengths |
US5935076A (en) * | 1997-02-10 | 1999-08-10 | University Of Alabama In Huntsville | Method and apparatus for accurately measuring the transmittance of blood within a retinal vessel |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3245939C2 (en) | 1982-12-11 | 1985-12-19 | Fa. Carl Zeiss, 7920 Heidenheim | Device for generating an image of the fundus |
DE4433827C2 (en) * | 1994-09-22 | 1999-01-07 | Zeiss Carl Jena Gmbh | Arrangement and method for measuring substance parameters in layers of media, in particular for calibration-free in vivo measurement of oxygen saturation in optically accessible blood vessels |
WO2000009004A2 (en) | 1998-08-13 | 2000-02-24 | Whitland Research Limited | Optical device |
DE19920157A1 (en) * | 1999-04-29 | 2000-11-02 | Univ Schiller Jena | Determination of parameters of substances in media, especially oxygen saturation in living tissues, comprises using model function to take account of both back scattered and reflected light |
US6501974B2 (en) * | 2001-01-22 | 2002-12-31 | Datex-Ohmeda, Inc. | Compensation of human variability in pulse oximetry |
US6711425B1 (en) * | 2002-05-28 | 2004-03-23 | Ob Scientific, Inc. | Pulse oximeter with calibration stabilization |
-
2002
- 2002-04-17 DE DE10217543A patent/DE10217543B4/en not_active Expired - Fee Related
-
2003
- 2003-04-17 US US10/511,483 patent/US7333842B2/en not_active Expired - Fee Related
- 2003-04-17 WO PCT/EP2003/004024 patent/WO2003086193A1/en not_active Application Discontinuation
-
2007
- 2007-12-18 US US12/002,678 patent/US20080194931A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4305398A (en) * | 1977-12-30 | 1981-12-15 | Minolta Camera Kabushiki Kaisha | Eye fundus oximeter |
US4253744A (en) * | 1978-05-12 | 1981-03-03 | Minolta Camera Kabushiki Kaisha | Optical system for light measurement of an eye fund |
US4485820A (en) * | 1982-05-10 | 1984-12-04 | The Johns Hopkins University | Method and apparatus for the continuous monitoring of hemoglobin saturation in the blood of premature infants |
US5119814A (en) * | 1990-07-25 | 1992-06-09 | Minnich Thomas E | Method and apparatus for monitoring blood loss via retinal venous oxygen saturation |
US5318022A (en) * | 1991-03-01 | 1994-06-07 | John Taboada | Method and apparatus for determining hemoglobin oxygenation such as in ocular and other vascular beds |
US5308919A (en) * | 1992-04-27 | 1994-05-03 | Minnich Thomas E | Method and apparatus for monitoring the arteriovenous oxygen difference from the ocular fundus |
US5935076A (en) * | 1997-02-10 | 1999-08-10 | University Of Alabama In Huntsville | Method and apparatus for accurately measuring the transmittance of blood within a retinal vessel |
US5776060A (en) * | 1997-02-20 | 1998-07-07 | University Of Alabama In Huntsville | Method and apparatus for measuring blood oxygen saturation within a retinal vessel with light having several selected wavelengths |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080221416A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | System and method for detection of macular degeneration using spectrophotometry |
WO2017117668A1 (en) * | 2016-01-05 | 2017-07-13 | Vasile Diaconu | On line and real time optic nerve blood oxygenation mapping |
Also Published As
Publication number | Publication date |
---|---|
WO2003086193A1 (en) | 2003-10-23 |
US20060063994A1 (en) | 2006-03-23 |
DE10217543B4 (en) | 2012-12-06 |
US7333842B2 (en) | 2008-02-19 |
DE10217543A1 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080194931A1 (en) | Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance varibles | |
US5983122A (en) | Apparatus and method for improved photoplethysmographic monitoring of multiple hemoglobin species using emitters having optimized center wavelengths | |
US6456862B2 (en) | Method for non-invasive spectrophotometric blood oxygenation monitoring | |
Liu et al. | Determination of optical properties and blood oxygenation in tissue using continuous NIR light | |
Schweitzer et al. | A new method for the measurement of oxygen saturation at the human ocular fundus | |
US5671735A (en) | Method and apparatus for detecting and measuring conditions affecting color | |
DE69227545T2 (en) | Oximeter for the reliable clinical determination of blood oxygen saturation in a fetus | |
EP1545298B1 (en) | Method and apparatus for spectrophotometric blood oxygenation monitoring | |
US5321265A (en) | Non-invasive testing | |
US5277181A (en) | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis | |
JP4490587B2 (en) | Device for noninvasive detection of oxygen metabolism in tissues | |
JP5175179B2 (en) | Improved blood oxygenation monitoring method by spectrophotometry | |
EP0352923A1 (en) | Spectrophotometric apparatus and method for monitoring oxygen saturation | |
Bertini et al. | Non-invasive bilirubinometry in neonatal jaundice | |
US9279763B2 (en) | Apparatus and method for measuring an analyte such as bilirubin, using light | |
WO1996014567A1 (en) | Rapid non-invasive optical analysis using broad bandpass spectral processing | |
JP4361822B2 (en) | Method and apparatus for measuring component concentration of target object | |
MacKenzie et al. | Oximetry using multispectral imaging: theory and application | |
US20070265513A1 (en) | Optical measurement of mitochondrial function in blood perfused tissue | |
JP2007530186A (en) | Spectrophotometric method for determining blood oxygen saturation in optically accessible blood vessels | |
KR19990022569A (en) | Method and apparatus for detecting and measuring the condition affecting color | |
US20140200419A1 (en) | Optical detection of carotenoid-related compounds in human bone and surrounding tissues | |
US6128516A (en) | Method and apparatus for detecting and measuring conditions affecting color | |
US7756569B2 (en) | Method for measuring the vessel diameter of optically accessible blood vessels | |
JPH07120384A (en) | Optical measuring method and device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |